AdaptHealth Corp (AHCO)
10.44
+0.03
(+0.29%)
USD |
NASDAQ |
Oct 04, 16:00
10.44
0.00 (0.00%)
After-Hours: 20:00
AdaptHealth SG&A Expense (TTM): 197.88M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 197.88M |
March 31, 2024 | 190.95M |
December 31, 2023 | 190.09M |
September 30, 2023 | 180.25M |
June 30, 2023 | 175.73M |
March 31, 2023 | 168.20M |
December 31, 2022 | 162.12M |
September 30, 2022 | 159.59M |
June 30, 2022 | 151.92M |
March 31, 2022 | 152.32M |
December 31, 2021 | 167.50M |
September 30, 2021 | 164.18M |
Date | Value |
---|---|
June 30, 2021 | 157.48M |
March 31, 2021 | 131.63M |
December 31, 2020 | 89.35M |
September 30, 2020 | 82.73M |
June 30, 2020 | 68.51M |
March 31, 2020 | 57.76M |
December 31, 2019 | 43.70M |
September 30, 2019 | 19.15M |
June 30, 2019 | 7.449M |
March 31, 2019 | 1.277M |
December 31, 2018 | 1.036M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
43.70M
Minimum
Dec 2019
197.88M
Maximum
Jun 2024
141.68M
Average
159.59M
Median
Sep 2022
SG&A Expense (TTM) Benchmarks
Cutera Inc | 144.63M |
IRIDEX Corp | 24.53M |
Stereotaxis Inc | 26.39M |
Electromed Inc | 34.49M |
Myomo Inc | 20.12M |